Symptomatic Netarsudil-Induced Verticillata

JAMA Ophthalmol. 2023 Nov 1;141(11):e232949. doi: 10.1001/jamaophthalmol.2023.2949. Epub 2023 Nov 16.
No abstract available

Plain language summary

This case report discusses a diagnosis of bilateral corneal verticillata in a woman aged 80 years who was using netarsudil eye drops for the treatment of primary open-angle glaucoma.

MeSH terms

  • Antihypertensive Agents / adverse effects
  • Benzoates
  • Glaucoma, Open-Angle* / drug therapy
  • Humans
  • Intraocular Pressure
  • Ocular Hypertension*
  • Ophthalmic Solutions / adverse effects
  • beta-Alanine

Substances

  • netarsudil
  • Benzoates
  • beta-Alanine
  • Ophthalmic Solutions
  • Antihypertensive Agents